Novel mouse monoclonal antibodies against Bordetella pertussis pertactin antigen with versatile applications
- 16 July 2023
- journal article
- research article
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 211, 106786
Abstract
No abstract availableKeywords
Funding Information
- Tehran University of Medical Sciences and Health Services (1400-3-296-54956)
This publication has 49 references indexed in Scilit:
- Pertussis: Challenges Today and for the FuturePLOS Pathogens, 2013
- Impact of Immunization Technology and Assay Application on Antibody Performance – A Systematic Comparative EvaluationPLOS ONE, 2011
- Comparison of recombinant and native pertactin of Bordetella pertussisVaccine, 2011
- Effectiveness of Adolescent and Adult Tetanus, Reduced‐Dose Diphtheria, and Acellular Pertussis Vaccine against PertussisClinical Infectious Diseases, 2010
- Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussisBMC Microbiology, 2009
- Pertussis in infants: Preventing deaths and hospitalisations in the very youngJournal of Paediatrics and Child Health, 2008
- Pertussis immunisation in adolescents and adults –Bordetella pertussisepidemiology should guide vaccination recommendationsExpert Opinion on Biological Therapy, 2006
- Bordetella pertussisProtein Pertactin Induces Type‐Specific Antibodies: One Possible Explanation for the Emergence of Antigenic Variants?The Journal of Infectious Diseases, 2003
- 5444159 Purification of a pertussis outer membrane protein : Jackson Gail; Fahim Raafat; Tan Larry; Chong Pele; Vose John; Klein Michel Richmond Hill, Canada assigned to Connaught Laboratories LimitedBiotechnology Advances, 1996
- Purification and analysis of the antigenicity of a 69000 Da protein fromBordetella pertussisFEMS Microbiology Letters, 1990